通过使用玻尿素毒素改善性:概述,重点关注组合方法
Loredana Raciti1, Gianfranco Raciti2, Antonio Ammendolia2
1Unità Spinale Unipolare, AO Cannizzaro, 98102 Catania, Italy.
Brain sciences
|July 27, 2024
概括
将毒素A型 (BoNT-A) 注射与物理治疗或机器人训练相结合,可以有效治疗性. 这种方法提高了患者的治疗结果,可能减少毒素剂量,副作用和成本.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 生物技术是生物技术.
背景情况:
- 性是一种常见的神经疾病,涉及肌肉度增加和高血压,导致肢体变形,疼痛和运动功能受损.
- 目前的治疗方法包括康复,口服药物,如巴克洛芬,注射疗法,如毒素A型 (BoNT-A).
- BoNT-A注射对于性是有效的,但通常需要与其他疗法结合,如果单独是不够的.
研究的目的:
- 审查将药理或非药理治疗与BoNT-A注射结合用于控制性的疗效.
- 评估辅助疗法的好处,包括传统的物理疗法和机器人辅助训练,当与BoNT-A一起使用时.
主要方法:
- 对调查性综合治疗策略的研究进行系统审查.
- 分析整合BoNT-A与物理治疗,机器人步行训练或其他辅助活动的治疗结果.
- 专注于涉及终端效应机器人系统的研究.
主要成果:
- 结合BoNT-A与传统物理治疗或机器人训练的联合治疗对患者的活动水平和上肢功能产生积极影响,即使在慢性中风患者中也是如此.
- 联合策略可能会增强BoNT-A的效果,从而减少剂量.
- 这种综合方法为改善患者表现和整体结果提供了一种有效的方法.
结论:
- 联合治疗策略包括BoNT-A注射和康复 (物理治疗或机器人) 是有效的性管理.
- 这些综合方法可以提高治疗效率,可能导致更低的肉毒素剂量,减少副作用,并降低医疗保健成本.
- 将BoNT-A与机器人辅助训练等先进康复技术相结合,代表了改善患者生活质量的有前途途途.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
664
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
664
Skeletal Muscle Relaxants: Therapeutic Uses
477
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
477
Spasmolytic Agents: Chemical Classification
874
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
874


